Volume 73, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


The assay of choice for serological detection of cysticercosis in humans and pigs is the enzyme-linked immunoelectrotransfer blot (EITB), a Western blot assay that relies on the use of seven lentil-lectin–purified glycoproteins (LLGPs) derived from metacestodes. The EITB is has a sensitivity of 98% and a specificity of 100% in detecting cysticercosis, yet scarcity of native source material and the labor-intensive process of metacestode purification hinder its practicality. These limitations have necessitated the reproduction of the EITB antigens in synthetic forms. Four chemically synthesized LLGP antigens, TS14, TS18var1, TSRS1, and TSRS2var1, were assayed individually by enzyme-linked immunosorbent assay (ELISA) and Western blot for immunoreactivity against a large cohort of sera from clinically defined neurocysticercosis patients. The sensitivity and specificity of all four of these antigens using the ELISA format were well below the standards set by the LLGP EITB, whereas results of the Western blot format closely mirrored those of the LLGP EITB.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization, 2002. Control of Neurocysticercosis: Report by the Secretariat. Fifty-fifth World Health Assembly; Provisional Agenda item 13.18. Washington, DC: World Health Organization. Report no. A55/23.
  2. Garcia HH, Gilman RH, Tsang VC, Gonzalez AE, 1997. Clinical significance of neurocysticercosis in endemic villages. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg 91 : 176–178. [Google Scholar]
  3. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J, 1990. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 150 : 325–327. [Google Scholar]
  4. Palacio LG, Jimenez I, Garcia HH, Jimenez ME, Sanchez JL, Noh J, Ahn L, Mora O, Giraldo M, Tsang VC, 1998. Neurocysticercosis in persons with epilepsy in Medellin, Colombia. The Neuroepidemiological Research Group of Antioquia. Epilepsia 39 : 1334–1339. [Google Scholar]
  5. Rajbhandari KC, 2004. Epilepsy in Nepal. Can J Neurol Sci 31 : 257–260. [Google Scholar]
  6. White AC Jr, 1997. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 24 : 101–113. [Google Scholar]
  7. Brand JA, Tsang VC, 1989. A rapid immunoblot assay (Western blot) to detect specific antibodies for human immunodeficiency virus, Schistosoma mansoni, and Taenia solium (cysticercosis). J Immunoassay 10 : 237–255. [Google Scholar]
  8. Tsang VC, Brand JA, Boyer AE, 1989. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 159 : 50–59. [Google Scholar]
  9. Tsang VC, Pilcher JA, Zhou W, Boyer AE, Kamango-Sollo EI, Rhoads ML, Murrell KD, Schantz PM, Gilman RH, 1991. Efficacy of the immunoblot assay for cysticercosis in pigs and modulated expression of distinct IgM/IgG activities to Taenia solium antigens in experimental infections. Vet Immunol Immunopathol 29 : 69–78. [Google Scholar]
  10. Pan American Health Organization, 1997. PAHO/WHO Informal Consultation on the Taeniosis/Cysticercosis Complex. Brasília, Brazil, August 23–25, 1995. Washington, DC: Pan American Health Organization, 6–9.
  11. Greene RM, Wilkins PP, Tsang VC, 1999. Diagnostic glycoproteins of Taenia solium cysts share homologous 14- and 18-kDa subunits. Mol Biochem Parasitol 99 : 257–261. [Google Scholar]
  12. Greene RM, Hancock K, Wilkins PP, Tsang VC, 2000. Taenia solium: molecular cloning and serologic evaluation of 14- and 18-kDa related, diagnostic antigens. J Parasitol 86 : 1001–1007. [Google Scholar]
  13. Hancock K, Khan A, Williams FB, Yushak ML, Pattabhi S, Noh J, Tsang VC, 2003. Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis. J Clin Microbiol 41 : 2577–2586. [Google Scholar]
  14. Hancock K, Pattabhi S, Greene RM, Yushak ML, Williams F, Khan A, Priest JW, Levine MZ, Tsang VC, 2004. Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis. Mol Biochem Parasitol 133 : 115–124. [Google Scholar]
  15. del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, Schantz PM, Evans CA, Flisser A, Correa D, Botero D, Allan JC, Sarti E, Gonzalez AE, Gilman RH, Garcia HH, 2001. Proposed diagnostic criteria for neurocysticercosis. Neurology 57 : 177–183. [Google Scholar]
  16. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, Tsang VC, 1991. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 164 : 1007–1009. [Google Scholar]
  17. Hancock K, Tsang VC, 1986. Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni. J Immunol Methods 92 : 167–176. [Google Scholar]
  18. Bradford MM, 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 : 248–254. [Google Scholar]
  19. Tsang VC, Greene RM, Pilcher JB, 1995. Optimization of the covalent conjugating procedure (NaIO4) of horseradish peroxidase to antibodies for use in enzyme-linked immunosorbent assay. J Immunoassay 16 : 395–418. [Google Scholar]
  20. Youden WJ, 1950. Index for rating diagnostic tests. Cancer 3 : 32–35. [Google Scholar]
  21. Hernandez M, Beltran C, Garcia E, Fragoso G, Gevorkian G, Fleury A, Parkhouse M, Harrison L, Sotelo J, Sciutto E, 2000. Cysticercosis: towards the design of a diagnostic kit based on synthetic peptides. Immunol Lett 71 : 13–17. [Google Scholar]
  22. Fleury A, Beltran C, Ferrer E, Garate T, Harrison LJ, Parkhouse RM, Garcia E, Fragoso G, Costa-Cruz J, Biondi G, Agapejev S, Sciutto E, 2003. Application of synthetic peptides to the diagnosis of neurocysticercosis. Trop Med Int Health 8 : 1124–1130. [Google Scholar]
  23. Butler JE, 2004. Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays. Methods Mol Med 94 : 333–372. [Google Scholar]

Data & Media loading...

  • Received : 03 Feb 2005
  • Accepted : 19 May 2005

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error